Lead Summary
Europe faces challenges in scaling innovative technology companies due to a prevailing risk-averse investment culture, while in the United States, national security concerns have led to restrictions on AI firms. Meanwhile, international scientific collaboration patterns reflect geopolitical tensions, influencing research partnerships.
Key Developments
-
Peter Wennink, former CEO of semiconductor equipment leader ASML, has identified Europe’s low appetite for risk as a significant barrier to the growth of innovative startups and scale-ups. He emphasizes that addressing this risk aversion is critical for Europe’s future technological competitiveness and success in sectors like semiconductors and venture capital sciencebusiness.net.
-
The Pentagon has officially designated AI company Anthropic as a supply chain risk, citing national security concerns. This designation may restrict Anthropic’s ability to engage with the Department of Defense and other federal agencies, reflecting heightened scrutiny of AI firms involved in critical technology supply chains npr.org.
-
A recent study reveals that US scientists show a marked preference for collaborating with German researchers over Chinese counterparts, even when research proposals are identical and in non-sensitive fields. This trend underscores how geopolitical factors continue to influence international scientific partnerships sciencebusiness.net.
-
In the context of European research funding, there is ongoing discussion about integrating philanthropic organizations as complementary funders for the next Horizon Europe program. Philanthropies could bring additional resources and impact-driven priorities to augment the program’s agenda-setting role sciencebusiness.net.
-
These developments follow recent EU proposals to implement "Made in EU" rules aimed at reducing reliance on China for strategic sectors, reflecting broader efforts to strengthen European technological sovereignty ground.news.
What to Watch Next
Stakeholders will be monitoring how Europe addresses its risk aversion to foster innovation and whether philanthropic partnerships materialize to bolster research funding. In the US, the impact of supply chain risk designations on AI companies’ operations and collaborations will be closely observed. Additionally, shifts in international research collaborations may continue to reflect geopolitical dynamics, influencing global science and technology progress.
